NCT03255343View on ClinicalTrials.gov

Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim

NAUnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions
Efficacy and Safety
Interventions
DEVICE

IMDENDRIM

In situ and intra tumoral injection of non removal nanodevice IMDENDRIM

Trial Locations (1)

Unknown

RECRUITING

Tongji University Eastern Hospital, Shanghai

Sponsors
All Listed Sponsors
collaborator

Shanghai Tongji Hospital, Tongji University School of Medicine

OTHER

lead

French Association for the Advancement Medical Research

OTHER